(Q37039217)

17 August 2017

The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement (English)

1 reference

17 August 2017

0 references

1 reference

Michael T French

1

1 reference

17 August 2017

Ioana Popovici

series ordinal

2

1 reference

17 August 2017

Lauren Tapsell

series ordinal

3

1 reference

17 August 2017

21 February 2008

1 reference

Journal of Substance Abuse Treatment

17 August 2017

1 reference

17 August 2017

35

1 reference

17 August 2017

4

1 reference

17 August 2017

462-469

1 reference

A critical review of accounting and economic methods for estimating the costs of addiction treatment

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Economic cost of the therapeutic workplace intervention added to methadone maintenance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Economic costs of drug abuse: financial, cost of illness, and services

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Is there a case for extended interventions for alcohol and drug use disorders?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

A research agenda for economic evaluation of substance abuse services

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Brief physician advice for problem drinking among older adults: an economic analysis of costs and benefits.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Cost-effectiveness analysis of a brief intervention delivered to problem drinkers presenting at an inner-city hospital emergency department

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

The economic cost of outpatient marijuana treatment for adolescents: findings from a multi-site field experiment.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Cost-benefit analysis of drug treatment services: review of the literature*

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Cost-effectiveness of inpatient substance abuse treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Drug treatment careers. A conceptual framework and existing research findings

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Financing and cost of standard and enhanced methadone treatment.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Organizational and client determinants of cost in outpatient substance abuse treatment.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

DATStats: results from 85 studies using the Drug Abuse Treatment Cost Analysis Program.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Service-level costing of drug abuse treatment.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614666

Benefit-cost analysis of brief physician advice with problem drinkers in primary care settings

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18294803

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Estimating the economic cost of substance abuse treatment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18294803

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JSAT.2007.12.008

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

18294803

1 reference